Prostate Cancer Detection: Performance of Radiomics Analysis in Multiparametric MRI

A Multiparametric MRI and Baseline-Clinical-Feature-Based Dense Multimodal Fusion Artificial Intelligence (MFAI) Model to Predict Castration-Resistant Prostate Cancer Progression

OBJECTIVES

The primary objective of this study was to identify whether patients with prostate cancer (PCa) could progress to denervation-resistant prostate cancer (CRPC) after 12 months of hormone therapy.

METHODS

A total of 96 PCa patients with baseline clinical data who underwent multiparametric magnetic resonance imaging (MRI) between September 2018 and September 2022 were included in this retrospective study. Patients were classified as progressing or not progressing to CRPC on the basis of their outcome after 12 months of hormone therapy. A dense multimodal fusion artificial intelligence (Dense-MFAI) model was constructed by incorporating a squeeze-and-excitation block and a spatial pyramid pooling layer into a dense convolutional network (DenseNet), as well as integrating the eXtreme Gradient Boosting machine learning algorithm. The accuracy, sensitivity, specificity, positive predictive value, negative predictive value, receiver operating characteristic curves, area under the curve (AUC) and confusion matrices were used as classification performance metrics.

RESULTS

The Dense-MFAI model demonstrated an accuracy of 94.2%, with an AUC of 0.945, when predicting the progression of patients with PCa to CRPC after 12 months of hormone therapy. The experimental validation demonstrated that combining radiomics feature mapping with baseline clinical characteristics significantly improved the model's classification performance, confirming the importance of multimodal data.

CONCLUSIONS

The Dense-MFAI model proposed in this study has the ability to more accurately predict whether a PCa patient could progress to CRPC. This model can assist urologists in developing the most appropriate treatment plan and prognostic measures.

Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations

Gastric cancer (GC) is the second most common cause of cancer-related death worldwide and a serious public health concern. This high death rate is mostly caused by late-stage diagnoses, which lead to poor treatment outcomes. Radiation immunotherapy and targeted therapies are becoming increasingly popular in GC treatment, in addition to surgery and systemic chemotherapy. In this review, we have focused on both in vitro and in vivo research, which presents a summary of recent developments in targeted therapies for gastric cancer. We explore targeted therapy approaches, including integrin receptors, HER2, Claudin 18, and glutathione-responsive systems. For instance, therapies targeting the integrin receptors such as the αvβ3 and αvβ5 integrins have shown promise in enhancing diagnostic precision and treatment efficacy. Furthermore, nanotechnology provides novel approaches to targeted drug delivery and imaging. These include glutathione-responsive nanoplatforms and cyclic RGD peptide-conjugated nanoparticles. These novel strategies seek to reduce systemic toxicity while increasing specificity and efficacy. To sum up, the review addresses the significance of personalized medicine and advancements in gastric cancer-targeted therapies. It explores potential methods for enhancing gastric cancer prognosis and treatment in the future.

Shearlet Transform Applied to a Prostate Cancer Radiomics Analysis on MR Images

For decades, wavelet theory has attracted interest in several fields in dealing with signals. Nowadays, it is acknowledged that it is not very suitable to face aspects of multidimensional data like singularities and this has led to the development of other mathematical tools. A recent application of wavelet theory is in radiomics, an emerging field aiming to improve diagnostic, prognostic and predictive analysis of various cancer types through the analysis of features extracted from medical images. In this paper, for a radiomics study of prostate cancer with magnetic resonance (MR) images, we apply a similar but more sophisticated tool, namely the shearlet transform which, in contrast to the wavelet transform, allows us to examine variations along more orientations. In particular, we conduct a parallel radiomics analysis based on the two different transformations and highlight a better performance (evaluated in terms of statistical measures) in the use of the shearlet transform (in absolute value). The results achieved suggest taking the shearlet transform into consideration for radiomics studies in other contexts.